Erratum: Radiation biology - can new concepts achieve better treatment outcomes?

Journal of Pharmacy and Pharmacology

Volumn 60, Issue 9, 2008, Pages 1243-1245

  Robson, Tracy ^a,b,c   Hirst, David G ^b,c  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b Association for Radiation Research

^c Local Organizing Committee ^*

Author keywords

[No Author keywords available]

Indexed keywords

BIBX 1382BS; CETUXIMAB; IBRITUMOMAB TIUXETAN; PROTEIN TYROSINE KINASE INHIBITOR; TOSITUMOMAB I 131;

CANCER RESEARCH; DNA DAMAGE; ERRATUM; HUMAN; IONIZING RADIATION; LOW ENERGY RADIATION; LYMPHOMA; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION DOSE; RADIATION HAZARD; RADIOBIOLOGY; RADIOIMMUNOTHERAPY; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION; EDITORIAL; METHODOLOGY; RADIATION INJURY;

HUMANS; NEOPLASMS; RADIATION INJURIES; RADIATION, IONIZING; RADIOBIOLOGY; TREATMENT OUTCOME;

EID: 49749112357     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.60.9.0018     Document Type: Erratum

References (0)